| 1X0J | A:; B:; C: | CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 |
| 2D9E | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN OF PEREGRIN |
| 2DAT | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN OF HUMAN SWI/SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CROMATIN SUBFAMILY A MEMBER 2 |
| 2DKW | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN OF HUMAN PROTEIN KIAA1240 |
| 2DVQ | A:; B:; C: | CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 COMPLEXED WITH ACETYLATED HISTONE H4 PEPTIDE |
| 2DVR | A:; B:; C: | CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 COMPLEXED WITH ACETYLATED HISTONE H4 PEPTIDE |
| 2DVS | A:; B:; C: | CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 COMPLEXED WITH ACETYLATED HISTONE H4 PEPTIDE |
| 2DVV | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF THE HUMAN BRD2 PROTEIN |
| 2E7N | A: | SOLUTION STRUCTURE OF THE SECOND BROMODOMAIN FROM HUMAN BROMODOMAIN-CONTAINING PROTEIN 3 |
| 2E7O | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN FROM HUMAN BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN 2B |
| 2G4A | A: | SOLUTION STRUCTURE OF A BROMODOMAIN FROM RING3 PROTEIN |
| 2GRC | A: | 1.5 A STRUCTURE OF BROMODOMAIN FROM HUMAN BRG1 PROTEIN, A CENTRAL ATPASE OF SWI/SNF REMODELING COMPLEX |
| 2H60 | A: | SOLUTION STRUCTURE OF HUMAN BRG1 BROMODOMAIN |
| 2I7K | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN OF HUMAN BRD7 PROTEIN |
| 2I8N | A: | SOLUTION STRUCTURE OF THE SECOND BROMODOMAIN OF BRD4 |
| 2KTB | B: | SOLUTION STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN POLYBROMO IN COMPLEX WITH AN ACETYLATED PEPTIDE FROM HISTONE 3 |
| 2NXB | A:; B: | CRYSTAL STRUCTURE OF HUMAN BROMODOMAIN CONTAINING PROTEIN 3 (BRD3) |
| 2OO1 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE BROMO DOMAIN 2 OF HUMAN BROMODOMAIN CONTAINING PROTEIN 3 (BRD3) |
| 2OSS | A: | CRYSTAL STRUCTURE OF THE BROMO DOMAIN 1 IN HUMAN BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) |
| 2OUO | A: | CRYSTAL STRUCTURE OF THE BROMO DOMAIN 2 IN HUMAN BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) |
| 2RFJ | A:27-135; B:29-135; C: | CRYSTAL STRUCTURE OF THE BROMO DOMAIN 1 IN HUMAN BROMODOMAIN CONTAINING PROTEIN, TESTIS SPECIFIC (BRDT) |
| 2YDW | A:; B:; C: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE INHIBITOR GW841819X |
| 2YEK | A:; B:; C: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE INHIBITOR GSK525762 (IBET) |
| 2YEL | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 WITH THE INHIBITOR GW841819X |
| 2YEM | A:; B: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD4 WITH THE INHIBITOR GW841819X |
| 2YW5 | A: | SOLUTION STRUCTURE OF THE BROMODOMAIN FROM HUMAN BROMODOMAIN CONTAINING PROTEIN 3 |
| 2YYN | A:; B:; C:; D: | CRYSTAL STURCTURE OF HUMAN BROMODOMAIN PROTEIN |
| 3AQA | A:; B:; C: | CRYSTAL STRUCTURE OF THE HUMAN BRD2 BD1 BROMODOMAIN IN COMPLEX WITH A BRD2-INTERACTIVE COMPOUND, BIC1 |
| 3DAI | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 |
| 3G0J | A:; B: | CRYSTAL STRUCTURE OF THE FIFTH BROMODOMAIN OF HUMAN POLY-BROMODOMAIN CONTAINING PROTEIN 1 (PB1) |
| 3G0L | A: | CRYSTAL STRUCTURE OF HUMAN BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN 2B (BAZ2B) |
| 3HME | A:; B: | CRYSTAL STRUCTURE OF HUMAN BROMODOMAIN CONTAINING 9 ISOFORM 1 (BRD9) |
| 3HMF | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN POLY-BROMODOMAIN CONTAINING PROTEIN 1 (PB1) |
| 3HMH | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN TBP-ASSOCIATED FACTOR RNA POLYMERASE 1-LIKE (TAF1L) |
| 3IU5 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN POLY-BROMODOMAIN CONTAINING PROTEIN 1 (PB1) |
| 3K2J | A:; B: | CRYSTAL STRUCTURE OF THE 3RD BROMODOMAIN OF HUMAN POLY-BROMODOMAIN CONTAINING PROTEIN 1 (PB1) |
| 3LJW | A:; B: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN POLYBROMO |
| 3LXJ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN AAA DOMAIN CONTAINING 2B (ATAD2B) |
| 3MB3 | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF PLECKSTRIN HOMOLOGY DOMAIN INTERACTING PROTEIN (PHIP) |
| 3MB4 | A:; B: | CRYSTAL STRUCTURE OF THE FIFTH BROMODOMAIN OF HUMAN POLY-BROMODOMAIN CONTAINING PROTEIN 1 (PB1) WITH NMP |
| 3MQM | A:; B: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN ASH1L |
| 3MXF | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH THE INHIBITOR JQ1 |
| 3NXB | A:; B: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN CECR2 |
| 3ONI | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD2 IN COMPLEX WITH THE INHIBITOR JQ1 |
| 3P5O | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH IBET INHIBITOR |
| 3Q2E | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BROMODOMAIN AND WD REPEAT-CONTAINING PROTEIN 1 ISOFORM A (WDR9) |
| 3Q2F | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH A TRIAZOLO LIGAND |
| 3QZS | B: | CRYSTAL STRUCTURE OF BPTF BROMO IN COMPLEX WITH HISTONE H4K16AC - FORM I |
| 3QZT | A: | CRYSTAL STRUCTURE OF BPTF BROMO IN COMPLEX WITH HISTONE H4K16AC - FORM II |
| 3RCW | A:; B:; C:; D:; E:; F:; G:; H: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRD1 |
| 3S91 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD3 IN COMPLEX WITH THE INHIBITOR JQ1 |
| 3S92 | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD3 IN COMPLEX WITH THE INHIBITOR JQ1 |
| 3SVF | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIHYDRO-QUINAZOLIN LIGAND |
| 3SVG | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 3,5-DIMETHYLISOXAZOL LIGAND |
| 3U5J | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH ALPRAZOLAM |
| 3U5K | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH MIDAZOLAM |
| 3U5L | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A BENZO-TRIAZEPINE LIGAND (BZT-7) |
| 3UV2 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF |
| 3UV4 | A:; B: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1 (TAF1) |
| 3UV5 | A:1398-1518 | CRYSTAL STRUCTURE OF THE TANDEM BROMODOMAINS OF HUMAN TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1 (TAF1) |
| 3UVD | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN TRANSCRIPTION ACTIVATOR BRG1 (SMARCA4) IN COMPLEX WITH N-METHYL-2-PYRROLIDONE |
| 3UVW | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K5ACK8AC) |
| 3UVX | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K12ACK16AC) |
| 3UVY | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K16ACK20AC) |
| 3ZYU | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH I-BET151(GSK1210151A) |
| 4A9E | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE |
| 4A9F | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-METHYLPYRROLIDIN-2-ONE |
| 4A9H | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2-METHYL-1,2,3, 4-TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE |
| 4A9I | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE |
| 4A9J | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4-HYDROXYPHENYL)ACETAMIDE |
| 4A9L | A: | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-DIMETHYL-6-( MORPHOLINE-4-SULFONYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE |
| 4A9M | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-CYCLOPENTYL-5-( 3,5-DIMETHYL-1,2-OXAZOL-4-YL)-2-METHYLBENZENE-1-SULFONAMIDE |
| 4A9N | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-CYCLOPROPYL-5-( 3,5-DIMETHYL-1,2-OXAZOL-4-YL)-2-METHYLBENZENE-1-SULFONAMIDE |
| 4A9O | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ETHYL-3-METHYL-4-PHENYL-1,2-OXAZOLE |
| 4AKN | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH TBUTYL-PHENYL-AMINO-DIMETHYL-OXAZOLYL-QUINOLINE-CARBOXYLIC ACID |
| 4ALG | A: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH IBET-151 |
| 4ALH | A:; B:; C: | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 DIMETHYL-4-PHENYL-1,2-OXAZOLE |
| 4BW1 | A: | THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 3,5 DIMETHYLISOXAXOLE LIGAND |
| 4BW2 | A: | THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 3,5 DIMETHYLISOXAXOLE LIGAND |
| 4BW3 | A: | THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 3,5 DIMETHYLISOXAXOLE LIGAND |
| 4BW4 | A: | THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 3,5 DIMETHYLISOXAXOLE LIGAND |
| 4C66 | A: | DISCOVERY OF EPIGENETIC REGULATOR I-BET762: LEAD OPTIMIZATION TO AFFORD A CLINICAL CANDIDATE INHIBITOR OF THE BET BROMODOMAINS |
| 4C67 | A: | DISCOVERY OF EPIGENETIC REGULATOR I-BET762: LEAD OPTIMIZATION TO AFFORD A CLINICAL CANDIDATE INHIBITOR OF THE BET BROMODOMAINS |
| 4CFK | A: | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY294002 |
| 4CFL | A: | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY303511 |
| 4CUP | A: | CRYSTAL STRUCTURE OF HUMAN BAZ2B IN COMPLEX WITH FRAGMENT-1 N09421 |
| 4CUQ | A: | CRYSTAL STRUCTURE OF HUMAN BAZ2B IN COMPLEX WITH FRAGMENT-2 N09594 |
| 4CUR | A: | CRYSTAL STRUCTURE OF HUMAN BAZ2B IN COMPLEX WITH FRAGMENT-3 N09555 |
| 4CUS | A: | CRYSTAL STRUCTURE OF HUMAN BAZ2B IN COMPLEX WITH FRAGMENT-4 N09496 |
| 4CUT | A: | CRYSTAL STRUCTURE OF HUMAN BAZ2B IN COMPLEX WITH FRAGMENT-5 N09428 |
| 4DON | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH A FRAGMENT 3,4-DIHYDRO-3-METHYL-2(1H)-QUINAZOLINON |
| 4E96 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH THE INHIBITOR PFI-1 |
| 4F3I | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH MS417 INHIBITOR |
| 4FLP | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRDT IN COMPLEX WITH THE INHIBITOR JQ1 |
| 4GPJ | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A ISOXAZOLYLBENZIMIDAZOLE LIGAND |
| 4HBV | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLIN LIGAND |
| 4HBW | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLINE LIGAND |
| 4HBX | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLIN LIGAND |
| 4HBY | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLIN LIGAND |
| 4HXK | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH 6,7-DIHYDROTHIENO[3,2-C]PYRIDIN-5(4H)-YL(1H-IMIDAZOL-1-YL)METHANONE INHIBITOR |
| 4HXL | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH 3-CYCLOHEXYL-N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL)AMINO]PHENYL}PROPANAMIDE INHIBITOR |
| 4HXM | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL)AMINO]PHENYL}BUTANAMIDE INHIBITOR |
| 4HXN | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH 4-(2-FLUOROPHENYL)-1,3-THIAZOL-2(3H)-ONE INHIBITOR |
| 4HXO | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH 3-{[(3-METHYL-1,2-OXAZOL-5-YL) METHYL]SULFANYL}[1,2,4]TRIAZOLO[4,3-A]PYRIDINE INHIBITOR |
| 4HXP | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH 4-(2-OXO-1,3-OXAZOLIDIN-3-YL)BENZAMIDE INHIBITOR |
| 4HXR | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]THIOPHENE-2-SULFONAMIDE INHIBITOR |
| 4HXS | A: | BRD4 BROMODOMAIN 1 COMPLEX WITH N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]-1-PHENYLMETHANESULFONAMIDE INHIBITOR |
| 4IOO | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF BRD4 IN COMPLEX WITH N-METHYLTRIMETHYLACETAMIDE |
| 4IOQ | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF BRD4 IN COMPLEX WITH PYRROLIDIN-2-ONE |
| 4IOR | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF BRD4 IN COMPLEX WITH DMSO |
| 4IR3 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH 1-[7-AMINO-1-(PYRIMIDIN-2-YL)INDOLIZIN-3-YL]ETHANONE (GSK2833282A) |
| 4IR4 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH 1-[7-(MORPHOLIN-4-YL)-1-(PYRIDIN-2-YL)INDOLIZIN-3-YL]ETHANONE (GSK2834113A) |
| 4IR5 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH 1-{1-[2-(HYDROXYMETHYL)PHENYL]-7-PHENOXYINDOLIZIN-3-YL}ETHANONE (GSK2847449A) |
| 4IR6 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH 1-{1-[2-(METHYLSULFONYL)PHENYL]-7-PHENOXYINDOLIZIN-3-YL}ETHANONE (GSK2838097A) |
| 4J0R | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 3,5-DIMETHYLISOXAZOL LIGAND |
| 4J0S | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 3,5-DIMETHYLISOXAZOL LIGAND |
| 4J1P | A: | X-RAY CRYSTAL STRUCTURE OF BROMODOMAIN 2 OF HUMAN BRD2 IN COMPLEX WITH RVX208 TO 1.08 A RESOLUTION |
| 4J3I | A: | X-RAY CRYSTAL STRUCTURE OF BROMODOMAIN COMPLEX TO 1.24 A RESOLUTION |
| 4KCX | A:; B: | BRDT IN COMPLEX WITH DINACICLIB |
| 4LC2 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRPF1B |
| 4LR6 | A: | STRUCTURE OF BRD4 BROMODOMAIN 1 WITH A 3-METHYL-4-PHENYLISOXAZOL-5-AMINE FRAGMENT |
| 4LRG | A: | STRUCTURE OF BRD4 BROMODOMAIN 1 WITH A DIMETHYL THIOPHENE ISOXAZOLE AZEPINE CARBOXAMIDE |
| 4LYI | A: | CRYSTAL STRUCTURE OF APO-BRD4(1) |
| 4LYS | A: | CRYSTAL STRUCTURE OF BRD4(1) BOUND TO COLCHICEINE |
| 4LYW | A: | CRYSTAL STRUCTURE OF BRD4(1) BOUND TO INHIBITOR XD14 |
| 4LZ2 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2A |
| 4LZR | A: | CRYSTAL STRUCTURE OF BRD4(1) BOUND TO COLCHICINE |
| 4LZS | A: | CRYSTAL STRUCTURE OF BRD4(1) BOUND TO INHIBITOR XD46 |
| 4MEN | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 5-METHYL-TRIAZOLOPYRIMIDINE LIGAND |
| 4MEO | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 2-METHYL-QUINOLINE LIGAND |
| 4MEP | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 3-CHLORO-PYRIDONE LIGAND |
| 4MEQ | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A 5-METHYL-TRIAZOLOPYRIMIDINE LIGAND |
| 4MR3 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLINONE LIGAND (RVX-OH) |
| 4MR4 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A QUINAZOLINONE LIGAND (RVX-208) |
| 4MR5 | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD2 IN COMPLEX WITH A QUINAZOLINONE LIGAND (RVX-OH) |
| 4MR6 | A: | CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD2 IN COMPLEX WITH A QUINAZOLINONE LIGAND (RVX-208) |
| 4NQM | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A TRIAZOLO-PHTHALAZINE LIGAND |
| 4NQN | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRD9 IN COMPLEX WITH A TRIAZOLO-PHTHALAZINE LIGAND |
| 4NR8 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH AN ISOXAZOLYL-BENZIMIDAZOLE LIGAND |
| 4NR9 | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH ACETYLATED LYSINE |
| 4NRA | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH COMPOUND-6 E11322 |
| 4NRB | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH COMPOUND-1 N01197 |
| 4NRC | A: | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BAZ2B IN COMPLEX WITH COMPOUND-3 N01186 |
| 4NUC | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH MS435 INHIBITOR |
| 4NUD | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH MS436 INHIBITOR |
| 4NUE | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH MS267 INHIBITOR |
| 4O70 | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH DINACICLIB |
| 4O71 | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH FLAVOPIRIDOL |
| 4O72 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH NU7441 |
| 4O74 | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH BI 2536 |
| 4O75 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH FOSTAMATINIB |
| 4O76 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH TG101209 |
| 4O77 | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB 202190 |
| 4O78 | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH GW612286X |
| 4O7A | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB-409514 |
| 4O7B | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB-284847-BT |
| 4O7C | A: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB-614067-R |
| 4O7E | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB-610251-B |
| 4O7F | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH SB-251527 |
| 4OGI | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH THE INHIBITOR BI-2536 |
| 4OGJ | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH THE INHIBITOR TG-101348 |
| 4PS5 | A:; B: | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH TG101348 |
)
)